HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Nuveen Asset Management LLC

Nuveen Asset Management LLC cut its stake in HealthEquity, Inc. (NASDAQ:HQY) by 9.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 548,725 shares of the company’s stock after selling 54,221 shares during the quarter. Nuveen Asset Management LLC owned approximately 0.63% of HealthEquity worth $52,650,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Arcadia Investment Management Corp MI acquired a new position in HealthEquity in the fourth quarter valued at approximately $26,000. Transce3nd LLC acquired a new position in HealthEquity in the fourth quarter valued at approximately $29,000. Smartleaf Asset Management LLC lifted its holdings in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after acquiring an additional 98 shares during the period. Proficio Capital Partners LLC acquired a new position in shares of HealthEquity during the 4th quarter worth approximately $39,000. Finally, UMB Bank n.a. raised its stake in shares of HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after buying an additional 164 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Stock Up 0.6%

Shares of HQY opened at $98.23 on Monday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The stock has a market capitalization of $8.50 billion, a price-to-earnings ratio of 90.12, a PEG ratio of 1.60 and a beta of 0.45. The stock has a 50 day moving average price of $87.88 and a 200 day moving average price of $97.12.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on HQY shares. The Goldman Sachs Group reduced their target price on HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a research note on Thursday, March 27th. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and reduced their target price for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Barrington Research reaffirmed an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a research note on Friday, April 11th. KeyCorp reduced their target price on HealthEquity from $110.00 to $100.00 and set an “overweight” rating for the company in a research note on Wednesday, April 16th. Finally, Wells Fargo & Company upped their target price on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and an average price target of $111.75.

Insider Buying and Selling

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the company’s stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares in the company, valued at $4,433,820.30. This represents a 13.55% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the sale, the director now owns 84,969 shares of the company’s stock, valued at approximately $6,597,842.85. The trade was a 6.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.